Female Sexual Dysfunction: Prevalence, Causes, and Treatments

    April 2015 in “ Cambridge University Press eBooks ”
    Nancy Phillips, Gloria Bachmann
    Image of study
    TLDR Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.
    Female sexual dysfunction (FSD) affects 30-50% of women, with a 43.1% point prevalence reported in a study of 31,581 females aged 18 and older. FSD includes disorders of desire, arousal, orgasm, and sex pain, and is caused by various factors such as neurological, endocrine, vascular, surgical, or psychosocial issues. Up to 12% of women experience distress due to sexual problems, yet less than one-third seek medical advice. FSD is more common in postmenopausal women, with an incidence of up to 68%. Treatments include hormone therapy and the PLISSIT model, but there are safety concerns and a lack of standardized dosing for hormone treatments. The document also discusses the need for a comprehensive approach to diagnosis and treatment, including the use of the Female Sexual Function Index in clinical trials and the FDA's guidelines for minimizing recall bias in research. It emphasizes the importance of addressing sexuality in women's health and the need for further research and training in human sexuality for medical professionals.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community 21 months on topical minoxidil and full HRT

      in Transgender  214 upvotes 11 months ago
      The conversation is about a transgender individual's experience with hair regrowth using topical minoxidil and hormone replacement therapy (HRT), expressing concern about the slow growth and thin appearance of their hair. Some responses encourage patience and highlight the variability of results, while others discuss the role of HRT and its effects.

      community How true is the statement: dead follicles don't grow back?

      in Research/Science  107 upvotes 1 month ago
      Hair follicles usually go dormant rather than die, and treatments like finasteride, minoxidil, and hormone therapy can sometimes reactivate them, though results vary. Complete regrowth is rare, especially in long-term bald areas, but some individuals see significant improvement with these treatments.

      community Low dose spiro with 5ARI inhibitor

      in Chat  2 upvotes 4 months ago
      Spironolactone, finasteride, and dutasteride are discussed for hair maintenance, with concerns about testosterone and side effects like gynecomastia. Spironolactone is noted for use in both bodybuilding and hormone therapy, with low doses considered for minimizing side effects.

      community 5 years of trying different hairloss treatment.

      in Treatment  6 upvotes 3 years ago
      The user tried various hair loss treatments including minoxidil, finasteride, hormone therapy, dutasteride, microneedling, and natural oils. They plan to continue their regimen and may consider surgical options if results are unsatisfactory.

      community I think I’m on to something

       22 upvotes 5 years ago
      The user shared their personal experience with hair loss, hormone imbalances, and treatments including testosterone boosters, natural estrogen blockers, and DHEA. They suggest that low-dose finasteride and natural hormone therapy could reduce hair loss with fewer side effects.

    Similar Research

    5 / 1000+ results